• Long-term sequelae of post-COVID-19 subjects from 19 centres across India

  Gadhave, S., Thekkinkattil, M., Chaudhary, A., Bendre, S., Bhattacharyya, P., Archana, B., … & Salvi, S. (2023). Long-term sequelae of post-COVID-19 subjects from 19 centres cross India.
• A narrative review on the Synchrobreathe™: A novel breath-actuated pressurised metered-dose inhaler for the treatment of obstructive airway diseases.

  Lavorini, F., Usmani, O. S., Salvi, S., Rote, K., Gaur, V., & Gogtay, J. (2023). A narrative review on the Synchrobreathe™: A novel breath-actuated pressurised metered-dose inhaler for the treatment of obstructive airway diseases. Respiratory Medicine, 107435.
• Absolute blood eosinophil counts among 3,763 healthy, asthmatic, and COPD subjects across India

  Dhumal, P., Singh, V., Sarkar, M., Padmanabhan, A., Swarnakar, R., Christopher, D.,… & Salvi, S. (2023). Absolute blood eosinophil counts among 3,763 healthy, asthmatic, and COPD subjects across India.
• An international, observational cohort study

  Aliberti S, Reyes LF, Faverio P, Sotgiu G, Dore S, Rodriguez AH, Soni NJ, Restrepo MI, Aruj PK, Attorri S, Barimboim E. Global initiative for meticillin-resistant Staphylococcus aureus pneumonia (GLIMP): an international, observational cohort study. The Lancet Infectious Diseases. 2016 Dec 1;16(12):1364-76.
• Study of 793 COPD patients treated by general practitioners (GPs), intensivists (IPs) and pulmonologists (Ps) across India.

  Sorte, Renu, Parthssarthy Bhattacharyya, P. Mahesh, Raja Dhar, Suryakant Tripathi, Rajesh Swarnakar, D. Christopher et al. “Study of 793 COPD patients treated by general practitioners (GPs), intensivists (IPs) and pulmonologists (Ps) across India.” (2015): PA1253.
• Drugs used by doctors to treat COPD across India. A study conducted by Respiratory Research Network of India (RRNI)

  Drugs used by doctors to treat COPD across India. A study conducted by Respiratory Research Network of India (RRNI) in: proceedings from National Conference on Pulmonary Diseases National College of Chest Physicians (India) & Indian Chest Society(NAPCON), 2015.
• Phenotype characterization of non cystic fibrosis bronchiectasis in India: baseline data from an Indian bronchiectasis registry.

  Dhar R, Mohan M, D’souza G, Rajagopalan S, Singh V, Jindal A, Archana B, Ghewade B, Joshi G, Sahasrabuddhe T. Phenotype characterization of non cystic fibrosis bronchiectasis in India: baseline data from an Indian bronchiectasis registry. Am J Respir Crit Care Med. 2017 Jan 1;195:A4726.
• Antibiotic prescription patterns for treating respiratory infections across intensive care unit (ICUs) in India

  Swarnakar, Rajesh, Nikita Jalan, Deepak Muthreja, Babaji Ghewade, Smaran Claudius, Sushant Meshram, Aditi Joshi et al. “Antibiotic prescription patterns for treating respiratory infections across intensive care unit (ICUs) in India.” (2016): PA2641.
• The Lancet Infectious Diseases

  Aliberti S, Reyes LF, Faverio P, Sotgiu G, Dore S, Rodriguez AH, Soni NJ, Restrepo MI, Aruj PK, Attorri S, Barimboim E. Global initiative for meticillin-resistant Staphylococcus aureus pneumonia (GLIMP): an international, observational cohort study. The Lancet Infectious Diseases. 2016 Dec 1;16(12):1364-76.